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The generalized Lotka-Volterra (gLV) equations, a classic model from theoretical ecology, describe
the population dynamics of a set of interacting species. As the number of species in these systems
grow in number, their dynamics become increasingly complex and intractable. We introduce Steady
State Reduction (SSR), a method that reduces a gLV system of many ecological species into two-
dimensional (2D) subsystems that each obey gLV dynamics and whose basis vectors are steady
states of the high-dimensional model. We apply this method to an experimentally-derived model of
the gut microbiome in order to observe the transition between “healthy” and “diseased” microbial
states. Specifically, we use SSR to investigate how fecal microbiota transplantation, a promising
clinical treatment for dysbiosis, can revert a diseased microbial state to health.
I. INTRODUCTION
The long-term behaviors of ecological models are prox-
ies for the observable outcomes of real-world systems.
Such models might try to predict whether a pathogenic
fungus will be driven to extinction [1], or whether a mi-
crobiome will transition to a diseased state [2]. In this pa-
per we explicitly account for this outcome-oriented per-
spective with Steady State Reduction (SSR). This method
compresses a generalized Lotka-Volterra (gLV) model of
many interacting species into a reduced two-state gLV
model whose two unit species represent a pair of steady
states of the original model.
This reduced gLV model is defined on the two-
dimensional (2D) subspace spanned by a pair of steady
states of the original model, and the subspace itself is
embedded within the high-dimensional ecological phase
space of the original gLV model. We prove that the
SSR-generated model is the best possible gLV approx-
imation of the original model on this 2D subspace. The
parameters of the reduced model are weighted combi-
nations of the parameters of the original model, with
weights that are related to the composition of the two
high-dimensional steady states. We note that SSR could
be extended to encompass three or more steady states,
but the resulting reduced systems would quickly become
analytically opaque. In Section II we describe SSR and
its implementation in detail.
We apply this method to the microbiome, which con-
sists of thousands of microbial species in mammals [3],
and which exhibits distinct “dysbiotic” microbial states
that are associated with diseases ranging from inflam-
matory bowel disease to cancer [4]. Microbial dynam-
ics are mediated by a complex network of biochemical
interactions (e.g. cellular metabolism or cell signaling)
performed by microbial and host cells [5, 6]. Ecologi-
cal models, including the gLV equations, seek to con-
solidate these myriad biochemical mechanisms into non-
specific coefficients that characterize the interactions be-
∗ ewj@physics.ucsb.edu
tween microbial populations. We consider one particular
genus-level gLV model of antibiotic-induced C. difficile
infection (CDI), which was fit with microbial abundance
data from a mouse experiment [7, 8].
This CDI model exhibits steady states that correspond
to experimentally-observed outcomes of health (i.e. re-
sistance to CDI) or dysbiosis (i.e. susceptibility to CDI).
The transition between these healthy and diseased states
is difficult to effectively probe due to the high dimen-
sionality of the system, so previous analyses have been
largely limited to numerical methods [9]. By reducing the
dimensionality of the original gLV model, SSR enables
this transition to be investigated with analytic dynam-
ical systems tools. We demonstrate the fidelity of SSR
as applied to this CDI model in Section III, and describe
the analytic tools accessible to reduced gLV systems in
Section IV.
Finally, we use SSR to analyze the clinically-inspired
scenario of antibiotic-induced CDI. Specifically, we exam-
ine the bacteriotherapy fecal microbiota transplantation
(FMT), in which gut microbes from a healthy donor are
engrafted into an infected patient, and which has shown
remarkable success in treating recurrent CDI [10]. In Sec-
tion IV we implement FMT in the reduced model and
successfully revert a disease-prone state to health, and
also find that the efficacy of FMT depends on the tim-
ing of its administration. In Section V we show that
this dependence on FMT timing, also present in the
experimentally-derived CDI model [9], is preserved un-
der SSR.
II. COMPRESSION OF GENERALIZED
LOTKA-VOLTERRA SYSTEMS
We begin by demonstrating how to compress the
high-dimensional ecological dynamics of the generalized
Lotka-Volterra (gLV) equations, given in Eq. (1), into an
approximate two-dimensional (2D) subspace. This pro-
cess, called Steady State Reduction (SSR), is depicted
schematically in Fig. 1. The idea behind SSR is to recast
a pair of fixed points of a high-dimensional gLV model
as idealized ecological species in a 2D gLV model, and to
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2characterize the interactions between these two compos-
ite states by taking a weighted average over the species
interactions of the high-dimensional system. Within this
subspace, these reduced dynamics constitute the best
possible 2D gLV approximation of the high-dimensional
gLV dynamics.
The gLV equations model the populations of N inter-
acting ecological species yi as
d
dt
yi(t) = yi(t)
ρi + N∑
j=1
Kijyj(t)
 , (1)
for i ∈ 1, . . . , N . In vector form, these microbial dy-
namics are written d~ydt =
∑N
i=1
dyi
dt yˆi. Here, the growth
rate of species i is ρi, and the effect of species j on species
i is given by the interaction term Kij . In the following
derivation, we assume this model observes distinct stable
fixed points ~ya and ~yb.
Define variables xa and xb in the direction of unit vec-
tors xˆa and xˆb that parallel the two steady states accord-
ing to xˆa ≡ ~ya/‖~ya‖2, and xˆb ≡ ~yb/‖~yb‖2, where ‖·‖k
is the k-norm. The 2D gLV dynamics on the subspace
spanned by xˆa and xˆb are given by
dxa
dt
= xa(µa +Maaxa +Mabxb), and
dxb
dt
= xb(µb +Mbaxa +Mbbxb).
(2)
ya
ecologicalstate space
y1y2
y3 y4,
etc.
,
xb
xa
yb
SSR approximation:
gLV dynamics:
FIG. 1. Schematic of Steady State Reduction (SSR). A gLV
system ofN species (Eq. (1)) exhibits two steady states ~ya and
~yb, characterized as diseased (red) and healthy (green). SSR
identifies the two-dimensional (2D) gLV system defined on
the 2D subspace spanned by the two high-dimensional steady
states (Eq. (2)) that best approximates the high-dimensional
system. Specifically, SSR prescribes 2D parameters (Eq. (3))
that minimize the deviation between the N-dimensional gLV
dynamics d~y/dt and the embedded 2D SSR-reduced dynamics
d~x/dt.
The in-plane dynamics on this subspace in vector form
are defined to be d~xdt =
dxa
dt xˆa +
dxb
dt xˆb.
SSR links the parameters of the in-plane dynamics to
the high-dimensional gLV dynamics by setting
µγ =
~ρ · (~y ◦2γ )
‖~yγ‖22
, for γ ∈ a, b, and
Mγδ =
(~y ◦2γ )
TK~yδ
‖~yγ‖22‖~yδ‖2
, for γ, δ ∈ a, b.
(3)
Here, the Hadamard square represents the element-wise
square of a vector, defined as ~v ◦2 = [v21 , v
2
2 , . . . , v
2
N ]
T .
The parameter definitions in Eq. (3) are valid when ~ya
and ~yb are orthogonal; when they are not, the cross-
interaction terms Mab and Mba become more compli-
cated, and are given in Eqs. (A.18) and (A.19) of the
Appendix.
This choice of parameters minimizes the deviation be-
tween the in-plane and high-dimensional gLV dynamics
 = ‖d~ydt − d~xdt ‖2 for any point on the subspace spanned
by xˆa and xˆb. This is proved in the Appendix by show-
ing that, when evaluated with the SSR-prescribed pa-
rameter values of Eq. (3), ∂∂ci = 0 for every coefficient
ci ∈ {µa, µb, Maa, Mab, Mba, Mbb}, and that ∂2∂ci∂cj > 0
for every pair of coefficients ci and cj .
Under this construction, the high-dimensional steady
states ~ya and ~yb have in-plane steady state counterparts
at (‖~ya‖2, 0) and (0, ‖~yb‖2), respectively. It is for this
reason we call this method Steady State Reduction. Fur-
ther, if ~ya and ~yb are stable and orthogonal, then the
corresponding 2D steady states are stable as well, which
guarantees the existence of a separatrix in the reduced
2D system. These properties are shown in the Supple-
mentary Information [11], which includes many other cal-
culations that accompany the results of this paper. We
provide a Python module that implements SSR on arbi-
trary high-dimensional gLV systems in the Supplemen-
tary Code [12].
If the ecological dynamics of the system lie entirely on
the plane spanned by xˆa and xˆb, the SSR approximation
is exact. In this case, the plane contains a slow manifold
on which the ecological dynamics evolve. Therefore, the
dynamics generated by SSR result from a linear approx-
imation of the slow manifold.
III. STEADY STATE REDUCTION APPLIED
TO A MICROBIOME MODEL
Thousands of microbial species populate the gut mi-
crobiome [3], but for modeling purposes it is common
to coarse-grain at the genus or phylum level. Recently,
many experimentally derived gLV microbiome models
have been constructed with tools such as MDSINE, a
computational pipeline that infers gLV parameters from
time-series microbial abundance data [13]. SSR is appli-
cable to any of these gLV systems, so long as it exhibits
two or more stable steady states.
3We consider one such experimentally derived gLV
model, constructed by Stein et al. [7], that studies CDI
in the mouse gut microbiome. This model takes the same
form as Eq. (1) and tracks the abundances of 10 different
microbial genera and the pathogen C. difficile (CD), all
of which can inhabit the mouse gut. The 11-dimensional
(11D) parameters of this model were fit with data from
an experimental mouse study [8]. The parameters of this
model, along with a sample microbial trajectory, are pro-
vided in the Supplementary Information [11].
Despite the fact that this model did not re-
solve individual bacterial species, it still captured the
clinically- and experimentally-observed phenomenon of
antibiotic-induced CDI, suggesting that the true micro-
biome’s dimensionality could be approximated by an 11-
dimensional model. SSR further simplifies the dimen-
sionality of the microbiome: instead of thousands of mi-
crobial species or even eleven dominant genera, with SSR
steady states of the microbiome (each of which are multi-
species equilibrium populations) are idealized as individ-
ual ecological populations.
This CDI model exhibits five steady states that are
reachable from experimentally measured initial condi-
tions [7]. In previous work, we identified which of these
steady states were susceptible or resilient to invasion by
C. difficile (CD) [9]. Based on this classification, we
interpret a CD-susceptible steady state ~ya of the 11D
model as “diseased,” and interpret a CD-resilient steady
state ~yb as “healthy.” Explicit details about each of these
states are provided in the Supplementary Information
[11]. These two states are used to demonstrate SSR.
The reduced 2D parameters are generated according
to Eq. (3). We introduce new scaled variables, za =
xa/‖~ya‖2, and zb = xb/‖~yb‖2, so that the 2D system
exhibits steady states at (1, 0) and (0, 1). In Fig. 2,
trajectories of the reduced system (solid lines) that orig-
inate from four initial conditions and tend toward either
the healthy (green) or diseased (red) steady states are
plotted. The 2D separatrix is also plotted (light grey),
which divides the basins of attraction of the two steady
states, and which is derived in Eq. (6) of the Section IV.
To compare the original and reduced models, we con-
sider 11D trajectories that originate from the 11D em-
bedding of the four 2D initial conditions [11]. The pro-
jections of these 11D trajectories onto the 2D subspace
spanned by ~ya and ~yb (dashed lines) are shown alongside
the corresponding 2D trajectories in Fig. 2. The in-plane
11D separatrix is also shown (dark grey), which is numer-
ically constructed by tracking the steady state outcomes
of a grid of initial conditions on the plane.
We note that ~ya and ~yb are nearly orthogonal. How-
ever, in the Supplementary Information we demonstrate
that the high-dimensional and SSR-reduced trajectories
and basins of attraction agree for four different imple-
mentations of SSR; in two of these implementations the
pairs of steady states were orthogonal, and in the other
two they were not [11]. It is important to understand
when SSR is a good approximation, and under what con-
0 1za ≡ xa‖~ya‖2
0
1
z b
≡
x
b
‖~y
b‖ 2
gLV (11D) trajectories
SSR (2D) trajectories
11D separatrix
2D separatrix
FIG. 2. Fidelity of Steady State Reduction (SSR). SSR is ap-
plied to an experimentally-derived 11-dimensional (11D) gLV
model of C. difficile infection (CDI) [7]. This model exhibits
steady states ~ya and ~yb that are vulnerable (diseased, red) and
resilient (healthy, green) to invasion by the pathogen C. diffi-
cile [11]. We consider 11D microbial trajectories whose initial
conditions lie the plane spanned by these two steady states,
and plot the in-plane projection of these trajectories (dashed
lines). The 2D SSR-generated dynamics (solid lines) are plot-
ted alongside these high-dimensional trajectories. The sepa-
ratrix of each system is also plotted: as a proxy for the 11D
separatrix (actually a 10-dimensional surface), the in-plane
separatix (dark grey) is numerically generated and plotted;
the 2D separatrix is exact and given in Eq. (6) (light grey).
The code used to generate this figure is available in the Sup-
plemental Code [12].
ditions it may be successfully applied— this issue will be
addressed in a future publication (in progress).
In the five realizations of SSR explored in this paper
and in the supplement, the basins of attraction and mi-
crobial trajectories are largely preserved through SSR.
Since the 11D system has been compressed (from 132
parameters to 6), it is not surprising that the low- and
projected high-dimensional trajectories do not exactly
match. Even so, the basins of attraction agree almost
entirely, and the dynamical trajectories share clear simi-
larities. The deviation between the original and reduced
systems is examined in more detail in the Supplemen-
tary Information [11]. The close agreement between the
original and reduced systems intimates the reductive po-
tential of SSR.
IV. ANALYSIS OF THE 2D GLV EQUATIONS
Having demonstrated a method of linking a high-
dimensional gLV system to a 2D gLV system via SSR, we
4now take advantage of the analytic accessibility of such
2D systems. We consider biologically relevant systems
that exhibit competitive dynamics by assuming µα > 0
for α ∈ a, b, and Mαβ < 0 for α, β ∈ a, b. These sys-
tems exhibit two stable and homogeneous fixed points at
(−µa/Maa, 0) and (0, −µb/Mbb). In this case, the sys-
tem will also possess a hyperbolic fixed point at (x∗a, x
∗
b)
with xa > 0 and xb > 0, which topologically guarantees
the existence of a separatrix.
In Section IV A this separatrix is explicitly calculated
for the 2D gLV system Eq. (2). This result, in conjunc-
tion with SSR, allows for an efficient approximation of
the high-dimensional separatrix. Then, Section IV B ex-
plores the steady state and transient dynamics of a nondi-
mensionalized form of the 2D gLV system with clinically-
inspired modifications.
A. Explicit form of the separatrix
The long-term dynamics of this system are dictated by
the basins of attraction of the stable steady states, and
these basins are delineated by a separatrix that, for topo-
logical reasons, must be the stable manifold of the hyper-
bolic fixed point (x∗a, x
∗
b). In Fig. 3 these basins are de-
picted topographically via isoclines of the split Lyapunov
function V (xa, xb) (lightly shaded contours), which acts
as a potential energy landscape [11, 14].
The separatrix h(xa) may be analytically computed in
a power series expansion about the hyperbolic fixed point
(x∗a, x
∗
b),
h(xa) =
∞∑
n=0
cn
n!
(xa − x∗a)n, (4)
which as an invariant manifold must satisfy [15]
dh(xa)
dxa
=
dxb
dt
/
dxa
dt
, (5)
resulting in the recursive relations
c0 = x
∗
b ,
c1 =
1
2Mabx∗a
[
Mbbx
∗
b −Maax∗a
−
√
(Mbbx∗b −Maax∗a)2 + 4MabMbax∗ax∗b
]
,
c2 =
2c1(Mba +Mbbc1 −Maa −Mabc1)
2x∗aMaa + 3x∗aMabc1 −Mbbx∗b
, and
cn =
1
(nx∗aMaa + (n+ 1)x∗aMabc1 −Mbbx∗b)
×
{
ncn−1(Mba +Mbbc1 − (n− 1)(Maa +Mabc1))
+ n!
n−1∑
`=2
[
c`
`! (n− `)! (Mbbcn−` − (n− `)Mabcn−`
−x∗aMabcn−`+1)
]}
, for n > 2,
(6)
as derived in Eqs. (S27-S38) [11]. This calculation allows
the a priori classification of the fate of a given initial
condition, without need for simulation. We note that
this algebraic calculation of the separatrix is consider-
ably faster than numerical methods that rely on relatively
costly quadrature computations. Further, in conjunction
with SSR, this analytic form offers an efficient approx-
imation to the in-plane separatrix of high-dimensional
systems.
B. Dynamical landscape of the 2D gLV equations
Next, we analyze a two-state implementation of the
gLV equations that parallels the clinically-inspired sce-
nario of antibiotic-induced CDI. In this scenario, antibi-
otics deplete a health-prone initial condition, requiring
administration of FMT in order to recover, as in Fig. 3.
FMT is implemented in the 2D gLV model by adding a
transplant of size s composed of the healthy steady state
(0, 1) to an evolving microbial state at a specified time
following administration of antibiotics.
We consider a nondimensionalized form of the gLV
equations Eq. (2) and designate nondimensionalized vari-
ables with a tilde [11]. Therapeutic interventions of an-
tibiotics and FMT are included in this model in a man-
ner consistent with previous approaches [7, 9]. In all, this
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FIG. 3. The success or failure of fecal microbiota transplan-
tation (FMT) depends on the timing of its administration in
a two-state gLV system (Eq. (7)). We consider a clinically-
inspired scenario that parallels antibiotic-induced CDI. First,
a health-prone initial condition (IC) is depleted by antibi-
otics (RX, orange). If FMT (brown) is administered shortly
after the antibiotics, the treatment steers the composition to
a healthy state (FMT success). If FMT administration is de-
layed, the microbial trajectory instead attains the diseased
state (FMT failure). The basins of attraction of the healthy
and diseased steady states are delineated by the separatrix
Eq. 6, and isoclines of the potential energy landscape (light
contours) are given by the split Lyapunov function Eq. (S47)
[11, 14].
clinically-inspired two-state gLV model is given by
dx˜a
dt
= x˜a(1− x˜a − M˜abx˜b)
+ x˜aεau(t) + waδ(t− t∗), and
dx˜b
dt
= x˜b(µb − M˜bax˜a − x˜b)
+ x˜bεbu(t) + wbδ(t− t∗),
(7)
which includes optional antibiotic administration u(t) op-
erating with efficacy ~ε, and optional FMT with trans-
plant ~w administered instantaneously at time t∗.
In the absence of antibiotics and FMT, the dynamical
system Eq. (7) exhibits three nontrivial steady states at
(1, 0), (0, µb), and (x˜
∗
a, x˜
∗
b) ≡ ( 1−M˜abµ˜b1−M˜abM˜ba ,
µ˜b−M˜ba
1−M˜abM˜ba ).
To simplify the presentation of our results in the main
text we assume µb = 1, though this assumption is relaxed
in the Supplementary Information [11].
As before, suppose the variable x˜a corresponds to a dis-
eased state, and x˜b corresponds to a healthy state. Also
assume the transplant ~w consists of exclusively healthy
microbes so that wa = 0. Figs. 3, 4, and 5 are generated
with parameter values M˜ab = 1.167 and M˜ba = 1.093,
which give typical results.
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FIG. 4. The FMT transplant size needed to revert an
antibiotic-depleted state back to health grows as FMT ad-
ministration is delayed. The minimum FMT transplant size
required to cure five distinct disease-prone microbial trajec-
tories, each evolving according to Eq. (7), are calculated and
plotted. As trajectories attain the diseased steady state, the
required transplant size approaches s∗. The required trans-
plant size changes at two different rates, α and β, with the
crossover point between these two rates at size sc indicated
by a hollow square. The transplant size dynamics ds/dt as
well as the rates α and β are derived in Eq. (9) and the sur-
rounding text.
Altering the fate of an initial condition requires cross-
ing the separatrix by some external means, which is
achieved through FMT. Fig. 3 shows two microbial time
courses in which long-term outcomes are determined by
the timing of FMT administration. At each point along a
microbial trajectory in the diseased basin of attraction,
the minimum FMT size s required to transfer the mi-
crobial state into the healthy basin of attraction is cal-
culated. We use this metric to quantify our notions of
“FMT efficacy.”
In clinical practice FMT administration varies in trans-
plant size, transplant composition, and how many trans-
plants are performed. Further, it is unclear how these fac-
tors influence the success of FMT [16]. For the purposes
of this paper, we consider a hypothetical FMT treatment
of size st (i.e. a horizontal cut across Fig. 4) and describe
how its success depends on the timing of its administra-
tion.
Fig. 4 presents the minimum FMT size s as a function
of time (main panel) for several trajectories that originate
in the diseased basin of attraction (inset), including the
main trajectory of Fig. 3. This minimum required FMT
size increases with time— often dramatically— and there
are two discernible rates of increase, denoted α and β
in Fig. 4. These two rates are related to the fast and
slow manifolds of the ecological system, which in turn
govern the minimum required transplant size dynamics
over time.
To reflect the importance of the separatrix in dictat-
ing the microbial dynamics, we change coordinates to the
eigenvectors (u, v) of the hyperbolic steady state, shown
in Fig. 5 (inset). In these coordinates the v-axis corre-
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FIG. 5. The role of timing in FMT administration. For
antibiotic-depleted disease-prone initial conditions in which
antibiotics have been cleared (u(t) = 0), FMT is most effec-
tive when administered immediately (t∗opt = 0, grey) or nearly
immediately (t∗opt > 0, colored) following antibiotic adminis-
tration. The optimal transplant time t∗opt is computed for any
initial condition (u0, v0) (colorbar) according to Eq. (S88) of
[11], which can reduce to Eq. (10). Two representative mi-
crobial trajectories are plotted in (u, v) (main panel) and
(xa, xb) (inset) coordinates. For v0 > 0 four possible FMT
transplants are shown, including the optimal one that occurs
at t∗opt = 2.1. For v0 < 0 it is always best to administer FMT
immediately following antibiotic administration.
sponds to the separatrix, and u is proportional to the
minimum FMT size required for a successful transplant
s, such that s = u/(uˆ · xˆb), where (uˆ, vˆ) and (xˆa, xˆb) are
the unit vectors associated with their associated coordi-
nates.
In this new (u, v) basis, the 2D gLV equations become
du
dt
= A10u−A11uv −A20u2, and
dv
dt
= −B01v −B02v2 +B20u2,
(8)
where each coefficient is a positive algebraic function
of the original gLV parameters given analytically in
Eqs. (S60-S74) [11]. When µb 6= 1, these equations con-
tain additional quadratic terms described in [11] that ac-
count for the nonlinearity of the separatrix. In the small
u and small v limit this model reduces to the lineariza-
tion about the hyperbolic fixed point. Near this fixed
point there is a separation of time scales between u and
v (B01/A10 > 1 always, with median of 5.9 and IQR of
[2.7, 9.1] over random parameter draws [11]), indicating
that there are inherent fast and slow manifolds in this
system.
This coordinate change also reveals the role of tim-
ing in FMT administration, since the minimum required
transplant size s is precisely governed by Eq. (8), by
proxy of u. To demonstrate this analytically, we consider
an initial condition condition (u0, v0) that is located near
the fast manifold in a system with clear separation of time
scales, so that (i) B20u
2
0 is negligible, (ii) A10 << B01,
and (iii) B02v
2
0 << B01v0 (though this assumption is re-
laxed in Eq. (S87) [11]). In this case, the dynamics in
the fast vˆ direction are approximately v(t) ≈ v0e−B01t,
and the required transplant size dynamics reduce to
ds
dt
= s
(
A10 −A20(uˆ · xˆb)s−A11v0e−B01t
)
. (9)
Thus, the required transplant size rates α and β in Fig. 4
are approximately α = ds(0)dt
∣∣
s=sc
, and β = ds(∞)dt
∣∣
s=sc
,
where sc is the transplant size required at the crossover
point between these rates (e.g. as shown in Fig. 4).
For an initial condition with v0 < 0, which occurs in
Fig. 3 when a nearly healthy state is depleted by antibi-
otics, α > β. In this case the required transplant size
monotonically increases until it attains s∗ at the infected
steady state, so it is best to administer FMT as soon
as possible. Alternatively, when v0 > 0, α < β. When
A11v0 is sufficiently large α becomes negative, which in-
dicates there is a nonzero transplant time at which the
required transplant size is minimized (corresponding to
ds
dt = 0). The concave-up trajectories in Fig. 4 exhibit
this optimal transplant time. For v0 > 0 and under the
same conditions for which Eq. (9) was derived, this opti-
mal transplant time t∗ is
t∗opt =
1
B01
ln
(
A11v0
A10 −A20u0
)
. (10)
This nonzero transplant time reflects ecological pressures
that temporarily drive the system closer to the separa-
trix, overpowering the slow unstable manifold. Two tra-
jectories that numerically recapitulate these two cases are
shown in Fig. 5.
V. SSR APPLIED TO FECAL MICROBIOTA
TRANSPLANTATION
In Section IV, FMT restored a CDI-prone microbial
state in a 2D gLV model. In previous work [9], we im-
plemented FMT in the previously mentioned 11D CDI
model [7] and observed similar success. Here, the behav-
ior of FMT in the CDI model and in its SSR counterpart
are shown to match closely, which indicates that SSR
preserves transient microbial dynamics.
Fig. 6 (inset) contains the in-plane projections of the
11D (dashed) and corresponding SSR-reduced 2D (solid)
microbial trajectories with initial conditions that lie on
the plane spanned by (yˆa, yˆb) (11D) and (zˆa, zˆb) (2D),
as in Fig. 2. Fig. 6 (main panel) plots the required trans-
plant size s at each state along the two trajectories: the
11D (dashed) transplant is composed of yˆa, and s is calcu-
lated numerically with a bisection method; the 2D (solid)
transplant is composed of zˆb = (0, 1), and s is computed
analytically with Eq. (6).
In both systems, the microbial trajectories follow a fast
stable manifold before switching to a slow manifold of
some hyperbolic fixed point. As in the 2D case, the flow
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FIG. 6. Transient dynamics are preserved under SSR. (inset)
Microbial trajectories of the CDI model (in-plane projection,
dashed) and the associated SSR-reduced model (solid) as in
Fig. 2 are shown. (main panel) At each time along these
trajectories, the minimum FMT size required to make the
state health-prone is plotted, for a transplant made up of ~yb
(11D, dashed) or (0, 1) (2D, solid). Phase space is linked to
the FMT size dynamics by indicating the time at which zb
begins to decrease with a solid square (2D) or diamond (11D)
in both the inset and main figure. Since the required FMT
size s is the distance between a state and the separatrix, the
similarity between the two time courses of s indicates that
SSR preserves transient dynamics.
along these fast and slow manifolds underpins how the
required transplant size s changes over time. In Fig. 6,
the transition between the fast and slow manifolds occurs
at 8.37 days in 11D (solid diamond, main panel and inset)
and at 8.31 days in 2D (solid square).
As in the 2D case, the transition between these man-
ifolds may result in a nonzero optimal transplant time
t∗opt. The main panel of Fig. 7 displays these optimal
transplant times over a range of initial conditions, in
which t∗opt is generated with the same numerical bisec-
tion method as previously mentioned. Many of the high-
dimensional initial conditions exhibit a non-zero optimal
transplant time, mirroring the results of Fig. 5. Further,
the high-dimensional optimal transplant times closely
match those predicted by SSR, which are displayed in
the inset of Fig. 7, and which were analytically calcu-
lated with Eq. (S88).
Since the SSR-reduced system largely preserves the
high-dimensional transplant time dynamics, and since
in the 2D nondimensionalized system t∗opt can be ex-
amined analytically, the high-dimensional optimal trans-
plant times may be approximated in terms of the high-
dimensional interaction parameters. First, for systems
well-approxiated by SSR, a nonzero optimal transplant
time can only exist when v0 > 0— this tends to occur
when the size of the initial condition is larger than that
of the steady state ~yb, and when its composition is simi-
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FIG. 7. Optimal transplant times are preserved under SSR.
Optimal transplant times t∗opt of the 11D Stein model (main
panel) largely match the predictions of its associated SSR-
reduced model (inset). In the high-dimensional model, t∗opt is
computed numerically (as in Fig. 6) for a grid of points on
the plane spanned by ~ya and ~yb for disease-prone initial con-
ditions (located underneath the separatrix, which is shown as
a thick black line). The spatial and temporal resolutions of
this simulation are δza = 0.025, δzb = 0.01, and δtopt = 0.15,
and the resulting data points were smoothed with a Gaus-
sian filter. (inset) We display the optimal transplant times
of the corresponding SSR-reduced model, as in Fig. 5. The
SSR-reduced parameters were nondimensionalized so that t∗opt
could be generated with Eq. (S88), and the resulting optimal
transplant time predictions were redimensionalized and plot-
ted. The inset and the main panel share the same colorbar.
lar to that of ~yb. For this class of initial conditions, topt
will be smaller when the eigenvalues of the semistable
fixed point (A10 and B01) are larger, or in terms of the
SSR-reduced parameters, when Mab/Mbb and Mba/Maa
are larger.
The similarities between the transient dynamics of the
high-dimensional and 2D systems, as well as the corre-
spondence in optimal transplant timings, suggest that
the theoretical analyses of Section IV may inform more
complex and highly-resolved systems.
VI. DISCUSSION
A. Compression of complex ecological systems
SSR differs from other model reduction techniques
[17, 18] since it preserves core observable ecological fea-
tures of the original model, namely steady states and
their stabilities. The behavior of the model on the tran-
sition between two of these steady states is approximated
by SSR. Though the implementations of SSR demon-
strated in this paper were accurate, in general the accu-
8racy of SSR is not obvious a priori ; therefore, in future
work it is important to carefully examine the circum-
stances under which SSR is effective. When SSR is ac-
curate, properties of the steady states the original model
may also be extracted from this approximation— for ex-
ample, the size of the basins of attraction in the approx-
imate system can inform the robustness of a given state
in the original system, and the separatrix of the reduced
model can approximate the slow manifold on which dy-
namics evolve in the original model. The speed-up gained
by leveraging the analytic tractability of these approxi-
mate systems highlights the utility of SSR.
Beyond applications to existing gLV models, SSR-
based methods could create two-state gLV systems from
raw microbial data by choosing basis vectors during the
fitting process that correspond to experimentally ob-
served steady states [19]. The resulting models would
describe interactions between steady states rather than
between individual species, and would consist of fewer
variables and parameters that have improved explana-
tory power. This perspective— which effectively changes
the basis vectors of a gLV model from species to steady
states— may inform the transitions between steady
states in ecological models.
B. Simplification of gLV-based FMT frameworks
Bacteriotherapy is a promising frontier of medicine
that relies on the notion that the microbiome’s com-
position can both influence and be influenced by dis-
ease. Then, the deliberate alteration of a dysbiotic mi-
crobiome, by FMT for example, might be a viable treat-
ment option for a range of diseases [20, 21]. Since FMT
does not contribute to antimicrobial resistance, it is an
emerging alternative to antibiotics [22, 23]. Clinical stud-
ies continue to regularly identify new diseases that are
treated by FMT [24–26].
In this paper we examined a bistable two-state gLV
model from a clinical perspective, in which interventions
such as FMT or antibiotics altered the outcome of a
microbial trajectory. The tractability of this two-state
system allowed for an explicit understanding of how the
efficacy of FMT is influenced by the timing of its admin-
istration following antibiotic treatment. In this model,
delaying the administration of FMT in disease-prone mi-
crobiomes could lead to its failure. Modifying the time
course of a treatment has innovated treatment strategies
in cancer immunotherapy [27] and HIV vaccination [28],
and the results of this two-state ecological model suggest
that treatment timing may be relevant for bacteriother-
apy as well.
Indeed, some circumstantial evidence exists that sup-
ports the predictions of the two-state model, in which
FMT efficacy is improved when administered shortly af-
ter antibiotics. Kang et al. [29] used a promising variant
of FMT to induce seemingly long-term changes in the
microbiome and symptoms of children with autism spec-
trum disorders. This FMT variant “Microbiota Transfer
Therapy” first prescribed the antibiotic vancomycin for
two weeks, then bowel cleaning, then a large FMT dose
of Standardized Human Gut Microbiota, and finally two
months of daily maitenance FMT doses. In their study,
they intended for the efficacy of FMT to be improved by
first clearing out the microbiome with antibiotics, which
is consistent with the results of the 2D gLV system. How-
ever, future experiments are needed to quantitatively test
the extent to which antibiotic-depleted states are recep-
tive to FMT-like therapies.
VII. CONCLUSION
Broadly, SSR realizes a progression towards the sim-
plification of dynamical systems: while linearization ap-
proximates a dynamical system about a single steady
state, SSR approximates a dynamical system about two
steady states. We have shown that SSR produces the
best possible in-plane 2D gLV approximation to high-
dimensional gLV dynamics. Further, we have demon-
strated the extent to which the 2D model captures the
basins of attraction and transient dynamics of an exper-
imentally derived model. In addition to the computa-
tional efficiency of this technique, which employs analytic
results rather than expensive simulations, SSR builds
an intuition for the high-dimensional system out of con-
nected 2D cross-sections.
By approximating this complex and classic ecolog-
ical model with analytically tractable ecological sub-
spaces, SSR anchors a high-dimensional system to well-
characterized 2D systems. Consequently, this technique
offers to unravel the complicated landscapes that accom-
pany complex systems and their behaviors.
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Appendix: Derivation of Steady State Reduction
Consider an N-dimensional gLV system given by
Eq. (1) that exhibits steady states ~ya and ~yb, with dy-
namics given by d~ydt =
∑N
i=1
dyi
dt yˆi. As in the main text,
9define variables xa and xb in the direction of the unit vec-
tors xˆa ≡ ~ya/‖~ya‖2, and xˆb ≡ ~yb/‖~yb‖2, where ‖·‖k is the
k-norm. Further consider the in-plane 2D gLV dynam-
ics that exist on the plane spanned by xˆa and xˆb. Here,
we prove that the parameters prescribed by Steady State
Reduction, given in Eq. (3), minimize the 2-norm of the
deviation ~ between the high-dimensional and in-plane
dynamics at every point on the plane.
Consider coefficients c = {c1, . . . , c6} that parame-
terize the 2D gLV equations,
dxa
dt
= xa (c1 + c2xa + c3xb) , and
dxb
dt
= xb (c4 + c5xa + c6xb) ,
(A.1)
so that the in-plane dynamics are d~xdt =
dxa
dt xˆa +
dxb
dt xˆb.
Any point on this plane can be written ~y = ~yaxa + ~ybxb.
The deviation between the high-dimensional and in-
plane dynamics ~ is
~(xa, xb) =
d~x
dt
− d~y
dt
, (A.2)
which is defined at every point on the plane (xa, xb). We
will show that the parameters precribed by SSR minimize
the 2-norm of this deviation ‖~‖2 at point on the plane.
The deviation ~ can be decomposed into the N-
dimensional unit vectors yˆi, so that ~ =
∑
i yˆii, where
the components i are given by
i = yaixa
(c1 − ρi) +
c2 − N∑
j=1
Kijyaj
xa +
c3 − N∑
j=1
Kijybj
xb

+ ybixb
(c4 − ρi) +
c5 − N∑
j=1
Kijyaj
xa +
c6 − N∑
j=1
Kijybj
xb

≡ 10,ixa + 20,ix2a + 11,ixaxb + 01,ixb + 02,ix2b ,
(A.3)
where components jk,i are defined to correspond to con-
tributions by xjax
k
b terms. Here, yai corresponds to the
ith component of the unit vector xˆa ≡ ~ya/‖~ya‖2. In the
same way, the deviation vector may be decomposed ac-
cording to
~ = ~10xa + ~20x
2
a + ~11xaxb + ~01xb + ~02x
2
b . (A.4)
Minimizing this deviation at each point (xa, xb) is
equivalent to minimizing each orthogonal contribution
~jk. Each contribution is a function of one or two param-
eters (~10(c1), ~20(c2), ~01(c4), ~02(c6), and ~11(c3, c5)),
which simplifies the minimization process.
We now find the set of optimal coefficients c∗ =
{c∗1, . . . , c∗6} that minimize the 2-norm of each contribu-
tion ‖~jk‖2. For convenience, we equivalently minimize
the square of this 2-norm. The Hadamard square rep-
resents the element-wise square of a vector, defined as
~v ◦2 = [v21 , v
2
2 , . . . , v
2
N ]
T .
The coefficient ‖~10‖22 is given by
‖~10‖22 =
N∑
i=1
y2ai(c1 − ρi)2. (A.5)
When minimized with respect to c1, this quantity obeys
d‖~10‖22
dc1
=
N∑
i=1
2y2ai(c1 − ρi) = 0, (A.6)
which is satified for
c∗1 =
∑N
i=1 y
2
aiρi∑N
i=1 y
2
ai
=
~y ◦2a · ~ρ
‖~ya‖22
. (A.7)
In a similar way, ‖~20‖22, ‖~01‖22, and ‖~02‖22 are minimized
when
c∗2 =
∑N
i=1
(
y2ai
∑N
j=1Kijyaj
)
∑N
i=1 y
2
ai
=
(~y ◦2a )
TK~ya
‖~ya‖32
, (A.8)
c∗4 =
∑N
i=1 y
2
biρi∑N
i=1 y
2
bi
=
~y ◦2b · ~ρ
‖~yb‖22
, (A.9)
and
c∗6 =
∑N
i=1
(
y2bi
∑N
j=1Kijybj
)
∑N
i=1 y
2
bi
=
(~y ◦2b )
TK~yb
‖~yb‖32
. (A.10)
Lastly, the squared norm of the cross-term ‖~11‖2 is
given by
‖~11‖22 =
N∑
i=1
yai
c3 − N∑
j=1
Kijybj

+ybi
c5 − N∑
j=1
Kijyaj
2 .
(A.11)
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Minimizing with respect to c3 and c5 results in
d‖~11‖22
dc3
=
N∑
i=1
2
y2ai
c3 − N∑
j=1
Kijybj

+yaiybi
c5 − N∑
j=1
Kijyaj

= 0,
(A.12)
and
d‖~11‖22
dc5
=
N∑
i=1
2
yaiybi
c3 − N∑
j=1
Kijybj

+y2bi
c5 − N∑
j=1
Kijyaj

= 0.
(A.13)
After rearranging terms, these conditions read
c3
N∑
i=1
y2ai + c5
N∑
i=1
yaiybi =
N∑
i=1
N∑
j=1
yaiKij(yaiybj + ybiyaj),
(A.14)
and
c3
N∑
i=1
yaiybi + c5
N∑
i=1
y2bi =
N∑
i=1
N∑
j=1
ybiKij(yaiybj + ybiyaj),
(A.15)
which are satisfied when
c∗3 =
∑N
i,j=1Kij(yaiybj + ybiyaj)
(∑N
k=1 yaiy
2
bk − ybiyakybk
)
(∑N
i=1 y
2
ai
)(∑N
i=1 y
2
bi
)
−
(∑N
i=1 yaiybi
)2 ,
(A.16)
and
c∗5 =
∑N
i,j=1Kij(yaiybj + ybiyaj)
(∑N
k=1 ybiy
2
ak − yaiyakybk
)
(∑N
i=1 y
2
ai
)(∑N
i=1 y
2
bi
)
−
(∑N
i=1 yaiybi
)2 .
(A.17)
However, when ~ya and ~yb are orthogonal, the cross-term
deviation ‖~11‖22 is simplified, and the optimal coefficients
c∗3 and c
∗
5 become
c∗3 =
∑N
i=1
(
y2ai
∑N
j=1Kijybj
)
∑N
i=1 y
2
ai
=
(~y ◦2a )
TK~yb
‖~ya‖22‖~yb‖2
, (A.18)
and
c∗5 =
∑N
i=1
(
y2bi
∑N
j=1Kijyaj
)
∑N
i=1 y
2
bi
=
(~y ◦2b )
TK~ya
‖~yb‖22‖~ya‖2
. (A.19)
Since the squared norms of the deviations ‖jk‖2 are
convex, the coefficient set c∗ is a global minimum for
‖~‖2. Therefore, we have identified the parameters that
minimize the deviation between the in-plane and high-
dimensional gLV dynamics for any point on the plane
spanned by ~ya and ~yb.
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